Medical pot bills die in Texas legislature as local dispensary calls for renewed action

Cansortium Inc. , a medical cannabis company that operates in Texas, said Friday it’s disappointed in the failure this week of two bills in the state legislature to expand medical marijuana in Texas. “For decades, cannabis prohibition has funneled thousands of Texans into the criminal justice system,” the company said. “With more than 80% of Texans supporting the decriminalization of cannabis and the legalization of medical cannabis in the state, we must continue to call on our elected leaders to act on the will of their constituents and right the wrongs of the past.” Cansortium is the parent of medical dispensary operator Fluent. Cansortium stock is down 29% in 2023 compared to a 21.3% loss by the AdvisorsShares Pure U.S. Cannabis ETF (MSOS).

-Steve Gelsi

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.


(END) Dow Jones Newswires

05-26-23 0806ET

Copyright (c) 2023 Dow Jones & Company, Inc.

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *